After a horror first half of 2016, iSelect guided to 2016 earnings before interest and tax (or EBIT) of between $15m and $18m. We thought that was aggressive – so count us pleased at its result (the benefits of low expectations! – Ed).
The damage done in the first half – particularly in iSelect's Health segment – meant 2016 was far worse than 2015 (see Table 1). Yet it’s the future that matters and iSelect’s 2016 second-half performance suggests the business has stabilised.